BIK-E715E

N/A

Report date: 2025/07/10 16:00:55
NME

Base Information

Drug NameBIK-E715E
Drug Alias NameBIK-E715E
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionDNA topoisomerase I inhibitorsIntegrin alpha-V/beta-3 bindersIntegrin alpha-V/beta-5 binders
TargetsDNA topoisomerase IIntegrin alpha-V/beta-3Integrin alpha-V/beta-5
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBIK Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBIK Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A